Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: Potential clinical and therapeutic relevance

Endocrinology

Volumn 148, Issue 8, 2007, Pages 3900-3907

  Alesci, Salvatore ^a   Perera, Shiromi M ^b   Lai, Edwin W ^b   Kukura, Christina ^b   Abu Asab, Mones ^c   Tsokos, Maria ^c   Morris, John C ^c   Pacak, Karel ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; NORADRENALIN; THYMIDINE KINASE;

ADRENAL CELL; ANIMAL CELL; ARTICLE; CATECHOLAMINE UPTAKE; CELL NUCLEUS; CELL STRUCTURE; CELL SURVIVAL; CHROMAFFIN CELL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; MITOCHONDRION; MOUSE; NONHUMAN; NORADRENALIN UPTAKE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; STRESS; TRANSGENE; ULTRASTRUCTURE;

ADENOVIRIDAE; ADRENAL GLAND NEOPLASMS; ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMAFFIN CELLS; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; NOREPINEPHRINE; PHEOCHROMOCYTOMA; THYMIDINE KINASE; TRANSGENES; TRITIUM;

EID: 34547116436     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0521     Document Type: Article

References (50)

1. Kolavic-Gray SA, Binn LN, Sanchez JL, Cersovsky SB, Polyak CS, Mitchell-Raymundo F, Asher LV, Vaughn DW, Feighner BH, Innis BL 2002 Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis 35:808-818
2. Munoz FM, Piedra PA, Demmler GJ 1998 Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 27:1194-1200
3. Sanchez JL, Binn LN, Innis BL, Reynolds RD, Lee T, Mitchell-Raymundo F, Craig SC, Marquez JP, Shepherd GA, Polyak CS, Conolly J, Kohlhase KF 2001 Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol 65:710-718
4. Zahradnik JM, Spencer MJ, Porter DD 1980 Adenovirus infection in the immunocompromised patient. Am J Med 68:725-732
5. Ali M, Lemoine NR, Ring CJ 1994 The use of DNA viruses as vectors for gene therapy. Gene Ther 1:367-384
6. Barzon L, Stefani AL, Pacenti M, Palu G 2005 Versatility of gene therapy vectors through viruses. Expert Opin Biol Ther 5:639-662
7. Zuckerman JB, Robinson CB, McCoy KS, Shell R, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Brown-Parr EC, Hughes JV, Tazelaar J, Baker C, Goldman MJ, Wilson JM 1999 A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther 10:2973-2985
8. Barzon L, Boscaro M, Palu G 2004 Endocrine aspects of cancer gene therapy. Endocr Rev 25:1-44
9. Barzon L, Pacenti M, Boscaro M, Palu G 2004 Gene therapy for thyroid cancer. Expert Opin Biol Ther 4:1225-1239
10. Lozier JN, Metzger ME, Donahue RE, Morgan RA 1999 Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood 94:3968-3975
11. Nunes FA, Furth EE, Wilson JM, Raper SE 1999 Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Hum Gene Ther 10:2515-2526
12. Marshall E 1999 Gene therapy death prompts review of adenovirus vector. Science 286:2244-2245
13. Stauber E, Card C 1978 Experimental intraamnionic exposure of bovine fetuses with subgroup 2, type 7 adenovirus. Can J Comp Med 42:466-472
14. Cutlip RC, McClurkin AW 1975 Lesions and pathogenesis of disease in young calves experimentally induced by a bovine adenovirus type 5 isolated from a calf with weak calf syndrome. Am J Vet Res 36:1095-1098
15. Medvedev N, Shastina GV 1978 [Morphology of the adrenal cortex in infants with generalized adenovirus infections]. Arkh Patol 40:32-36 (Russian)
16. Schachtner S, Buck C, Bergelson J, Baldwin H 1999 Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Ther 6:1249-1257
17. Senoo M, Matsubara Y, Fujii K, Nagasaki Y, Hiratsuka M, Kure S, Uehara S, Okamura K, Yajima A, Narisawa K 2000 Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative TaqMan-polymerase chain reaction assay. Mol Genet Metab 69:269-276
18. Yang EY, Cass DL, Sylvester KG, Wilson JM, Adzick NS 1999 BAPS Prize-1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British Association of Paediatric Surgeons. J Pediatr Surg 34:235-241
19. Tajima T, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G 1999 Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice. Gene Ther 6:1898-1903
20. Alesci S, Ramsey WJ, Bornstein SR, Chrousos GP, Hornsby PJ, Benvenga S, Trimarchi F, Ehrhart-Bornstein M 2002 Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy. Proc Natl Acad Sci USA 99:7484-7489
21. Alesci S, Chrousos GP, Pacak K 2002 Genomic medicine: exploring the basis of a new approach to endocrine hypertension. Ann NY Acad Sci 970:177-192
22. Lenders JW, Eisenhofer G, Mannelli M, Pacak K 2005 Phaeochromocytoma. Lancet 366:665-675
23. O'Riordain DS, Young Jr WF, Grant CS, Carney JA, van Heerden JA 1996 Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20:916 -921; discussion 922
24. Ehrhart-Bornstein M, Haidan A, Alesci S, Bornstein SR 2000 Neurotransmitters and neuropeptides in the differential regulation of steroidogenesis in adrenocortical-chromaffin co-cultures. Endocr Res 26:833-842
25. Unsicker K, Muller TH 1981 Purification of bovine adrenal chromaffin cells by differential plating. J Neurosci Methods 4:227-241
26. Powers JF, Evinger MJ, Tsokas P, Bedri S, Alroy J, Shahsavari M, Tischler AS 2000 Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 302:309-320
27. Wildner O, Morris JC, Vahanian NN, Ford Jr H, Ramsey WJ, Blaese RM 1999 Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Gene Ther 6:57-62
28. Jaques Jr S, Tobes MC, Sisson JC, Baker JA, Wieland DM 1984 Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 26:539-546
29. Chrousos GP, Gold PW 1992 The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244-1252
30. Li X, Drakulich DA, Zhang P, Shen M, Weber GA, Ikezu T, Hexum TD 2002 Transduction of bovine adrenal chromaffin cells using a recombinant adenovirus expressing GFP. J Neurosci Methods 122:91-96
31. Kobayashi H, Yanagita T, Yokoo H, Wada A 2003 Pathophysiological function of adrenomedullin and proadrenomedullin N-terminal peptides in adrenal chromaffin cells. Hypertens Res 26(Suppl):S71-S78
32. Livett BG, Boksa P, Dean DM, Mizobe F, Lindenbaum MH 1983 Use of isolated chromaffin cells to study basic release mechanisms. J Auton Nerv Syst 7:59-86
33. 2+ sensor-1 in bovine chromaffin cells. J Neurosci 22:2427-2433
34. 2+]i and trigger exocytosis in bovine chromaffin cells. Neuropharmacology 51:18-26
35. Ashery U, Betz A, Xu T, Brose N, Rettig J 1999 An efficient method for infection of adrenal chromaffin cells using the Semliki Forest virus gene expression system. Eur J Cell Biol 78:525-532
36. Wick PF, Senter RA, Parsels LA, Uhler MD, Holz RW 1993 Transient transfection studies of secretion in bovine chromaffin cells and PC12 cells. Generation of kainate-sensitive chromaffin cells. J Biol Chem 268:10983-10989
37. Wilson SP, Liu F, Wilson RE, Housley PR 1995 Optimization of calcium phosphate transfection for bovine chromaffin cells: relationship to calcium phosphate precipitate formation. Anal Biochem 226:212-220
38. Hoenig EM, Margolis G, Kilham L 1974 Experimental adenovirus infection of the mouse adrenal gland. II. Electron microscopic observations. Am J Pathol 75:375-394
39. Margolis G, Kilham L, Hoenig EM 1974 Experimental adenovirus infection of the mouse adrenal gland. I. Light microscopic observations. Am J Pathol 75:363-374
40. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ 1999 Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260:712-717
41. Mason JW, Buescher EL, Belfer ML, Artenstein MS, Mougey EH 1979 A prospective study of corticosteroid and catecholamine levels in relation to viral respiratory illness. J Human Stress 5:18-28
42. Moolten FL 1986 Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281
43. Moolten FL, Wells JM 1990 Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300
44. van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF, Hospers GA 2002 Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2:307-322
45. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H 1996 Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 93:1831-1835
46. Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V 1995 Intercellular communication and carcinogenesis. Mutat Res 333:181-188
47. Wolkersdorfer GW, Bornstein SR, Higginbotham JN, Hiroi N, Vaquero JJ, Green MV, Blaese RM, Aguilera G, Chrousos GP, Ramsey WJ 2002 A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer. Horm Metab Res 34:279-287
48. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD 2001 Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727-729
49. Ilias I, Shulkin B, Pacak K 2005 New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol Metab 16:66-72
50. Pacak K, Eisenhofer G, Goldstein DS 2004 Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568-580